29.01.2013 Views

Radiofrequency ablation for uncomplicated varicose veins

Radiofrequency ablation for uncomplicated varicose veins

Radiofrequency ablation for uncomplicated varicose veins

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

M S Gohel and A H Davies. RFA <strong>for</strong> <strong>uncomplicated</strong> <strong>varicose</strong> <strong>veins</strong> Original article<br />

<strong>ablation</strong> catheter, the vein is ablated in 7 cm<br />

segments with extrinsic compression applied<br />

using a roll of crêpe bandage. The manufacturers<br />

recommend double treatment of the<br />

most proximal venous segment (near the SFJ)<br />

and single treatment of subsequent venous<br />

segments. Immediately following the <strong>ablation</strong>,<br />

the patency and compressibility of the femoral<br />

vein (<strong>for</strong> GSV <strong>ablation</strong>) should be verified with<br />

ultrasound.<br />

(7) Postoperative management, follow-up and outcome<br />

surveillance<br />

There is no consensus on optimal type or duration<br />

of compression following RFA, but TEDS,<br />

or class I or II above knee compression stockings<br />

worn <strong>for</strong> one to two weeks are common regimens.<br />

Recent guidelines from the American<br />

Venous Forum <strong>for</strong> the reporting of studies of<br />

endovenous treatment recommended early<br />

(,1 month) and late postoperative duplex<br />

scans. Clearly, local resource availability and<br />

clinician preference will dictate local follow-up<br />

and imaging protocols. It should be noted that<br />

the most recent NICE guidance <strong>for</strong> RFA was<br />

published in 2003 and this concluded that the<br />

procedure was safe and efficacious, but commented<br />

on the lack of long-term studies and<br />

recommended audit of outcomes.<br />

Results following radiofrequency<br />

<strong>ablation</strong><br />

When interpreting these results, it should be noted<br />

that the vast majority of published studies report<br />

outcomes using the VNUS Closure TM continuous<br />

pull-back catheter, whereas the VNUS ClosureFast TM<br />

segmental <strong>ablation</strong> catheter is the device primarily<br />

marketed by VNUS and growing in popularity.<br />

A total of 23 published reports, consisting of three randomized<br />

trials, two meta-analyses and 15 prospective<br />

observational studies were included in this review.<br />

Only one prospective case series using the VNUS<br />

ClosureFast TM catheter was identified. Details of the<br />

studies included are presented in Table 1.<br />

Technical success and clinical outcomes<br />

Although there is significant heterogeneity between<br />

clinical studies and variations in reported outcomes,<br />

recanalization of the treated venous segment is commonly<br />

reported as a marker of technical success.<br />

VNUS closure<br />

Reported vein closure rates vary between 67% and<br />

100% (Table 1). In a recent meta-analysis, the early<br />

technical success following RFA was found to be<br />

89% (3 months), reducing to 80% after five years. 2<br />

These figures compared favourably to traditional<br />

surgery and foam sclerotherapy, but were lower<br />

than endovenous laser <strong>ablation</strong>. By far, the largest<br />

patient series treated by VNUS Closure TM was published<br />

in 2005 and reported five-year clinical and anatomical<br />

outcomes following RFA in 1006 patients<br />

(1222 legs). 3 Data were collected from a prospective<br />

international registry and occlusion rates of 87.2%<br />

were seen at five years. Significant improvements in<br />

pain, fatigue and oedema were seen up to five years<br />

and interestingly, these improvements were present<br />

despite recurrent truncal reflux. Recurrent varicosities<br />

were seen in 27% of patients at five years and anatomical<br />

failure of RFAwas an independent risk factor<br />

<strong>for</strong> varicosity recurrence. 3 Within randomized<br />

studies, recurrent varicosities were seen in 48/217<br />

(22%) of patients at four years. 4<br />

VNUS ClosureFast TM<br />

The only published study reporting outcomes<br />

following VNUS ClosureFast TM was published in<br />

early 2008. The occlusion rate following segmental<br />

RFA was 99.6% at two years and 70% of treated<br />

patients did not require any analgesia postprocedure.<br />

5 A direct comparison of postoperative<br />

pain scores between RFA and laser <strong>ablation</strong> has<br />

been conducted in the Recovery trial sponsored by<br />

VNUS (unpublished data), but preliminary results<br />

showed significant lower pain scores following<br />

VNUS ClosureFast TM . 6<br />

Quality-of-life changes<br />

Studies of quality of life are scarce, but significant<br />

improvements in disease-specific quality-of-life following<br />

RFA were reported in the EVOLVeS study,<br />

using the CIVIQ2 questionnaire. 7,8 Moreover, these<br />

quality-of-life gains were greater than patients<br />

treated with traditional venous surgery.<br />

Cost-effectiveness of treatment<br />

To date, there have been few studies assessing the<br />

cost-effectiveness of RFA <strong>for</strong> the treatment of <strong>varicose</strong><br />

<strong>veins</strong>. In a small randomized study of 28<br />

patients, a basic cost-analysis demonstrated that<br />

VNUS Closure was more expensive than conventional<br />

surgery in terms of direct costs, but the<br />

Phlebology 2009;24 Suppl 1:42–49 45

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!